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Background. Somatic cells in vitro have a finite life ex-
pectancy before entering a state of senescence. If this state
has an in vivo counterpart, it could contribute to organ aging.
We have previously shown that human kidney cortex displays
telomere shortening with age. In the present study, we evaluated
the relationship between renal age in humans and a number of
phenomena associated with cellular senescence in vitro.
Methods. Human kidney specimens were obtained at 8 weeks
to 88 years of age and were assessed for changes related to aging.
Results. We found that human kidneys expressed relatively
constant levels of mRNAs for genes potentially related to senes-
cence. Among the candidate genes surveyed, the cell cycle reg-
ulator p16INK4a emerged with the strongest association with
renal aging for both mRNA and protein expression. Prolifer-
ation as measured by Ki-67 expression was inversely correlated
with p16INK4a expression, compatible with a role for p16INK4a
as an irreversible cell cycle inhibitor. Cyclooxygenase 1 and 2
(COX-1 and COX-2) mRNA expression was elevated in older
kidneys, associated with increased protein expression. Com-
parison of gene expression with age-related histologic changes
revealed that glomerulosclerosis correlated with p16INK4a and
p53, whereas interstitial fibrosis and tubular atrophy were asso-
ciated with p16INK4a, p53, COX-1, transforming growth factor-
b1 (TGF-b1), and heat shock protein A5 (HSPA5).
Conclusion. We conclude that some changes observed in cel-
lular senescence in vitro do occur in human kidney with age,
particularly in the renal cortex, in some cases correlating with
histologic features. P16INK4a emerged with the most consistent
correlations with age and histologic changes and inversely cor-
related with cell replication.
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Kidney aging is an important problem not only be-
cause normal aging reduces renal function but also be-
cause of the high frequency of end-stage renal disease
in the elderly (USRDS 2000 Annual Report). It is possi-
ble that interactions between aging and diseases stresses
contribute to renal failure in the elderly. Old kidneys of-
ten perform poorly when transplanted, and donor age
represents a major correlate of transplant survival [1].
The mechanisms of decline in organ function with age
may be instructive about the mechanisms of decline in
disease states, since stress could theoretically accelerate
some aging changes. Kidney aging is also of interest as a
general model for organ aging because renal function can
be more readily quantitated in longitudinal studies than
the changes in other organs [2].
The molecular basis of aging in organs is not known.
Theories of aging include oxidative damage, genomic in-
stability (including telomere loss), genetic programming
and cell death [3]. One phenomenon that may be rele-
vant to aging is the phenotype of senescence in cultured
somatic cells. Cultured mammalian somatic cells cease
cycling after a finite number of population doublings and
enter a state of senescence [4]. The phenotype of cells
in this state differs between human and rodent fibro-
blasts [5]. Human cellular senescence is called replicative
senescence and is accompanied by loss of telomeres, the
DNA repeats at the ends of chromosomes that shorten in
dividing normal somatic cells because of a lack of telom-
erase [6]. Replicative senescence in human fibroblasts can
be bypassed by transfection with telomerase [7]. In con-
trast, mouse and rat telomeres are relatively long and
show little shortening during their life expectancy [5], and
telomerase is active in almost all mouse tissues [8]. We
have previously shown that telomere shortening occurs
in human kidneys with age [9], whereas in rodent kidneys
telomeres are much longer and show minimal shortening
with age [10] (Melk et al, unpublished data). In mice and
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rats the cell cycle regulator p16INK4awas strongly associ-
ated with aging [10] [abstract; Melk et al, Am J Transplant
2:221, 2002], but other markers associated with cellular
senescence in vitro were not.
In this study, we focused on the expression of p16INK4a
in human kidneys. We also surveyed other genes impor-
tant for senescence for their relationship with age. We
included a number of genes encoding cell cycle regu-
lators: cyclin dependent kinase 4 (CDK4) [11–13], p53
[14–16] and its transactivational targets p21CIP1/WAF1 [17]
and growth arrest and DNA-damage inducible protein 45
(GADD45) [18], p14ARF [19, 20], human double minute 2
(HDM2) [21], proliferating cell nuclear antigen (PCNA)
[22, 23], and RAD23. We also included genes whose ex-
pression was increased in cultured fibroblast taken from
aged donors [24]: matrix metalloproteinase-1 (MMP-1),
plasminogen activator inhibitor-1 (PAI-1), transform-
ing growth factor-b1 (TGF-b1), cyclooxygenase 1 and 2
(COX-1 and COX-2). Finally, we studied genes to reflect
dysfunction of the mitochondria (LON protease) [25] or
the endoplasmic reticulum [HSPA5 and growth arrest
and DNA-damage inducible protein 153 (GADD153)]
[26].
METHODS
Kidneys
Human kidney samples were derived from total
nephrectomies, biopsies at time of transplantation, and
from autopsies. Certain samples were the same published
previously [9]. Whenever possible, cortex and medulla
were collected separately. A total of 42 samples were in-
vestigated and considered “normal” since their histology
was within the limits of changes expected for age based
on previous studies in normal kidneys [27–31] (D.C.R.).
These normal kidneys were derived from autopsies
(N = 3), zero biopsies at time of transplantation (N =
5), or nephrectomies (N = 34). Nephrectomies were per-
formed mainly because of renal malignancies [renal cell
carcinoma (N = 25), oncytoma (N = 1), or transitional
cell carcinoma (N = 3), metastatic lung cancer (N = 1),
Wilms’ tumor (N = 2)], but included also one case of a be-
nign tumor (angiolipoma) and discarded organs not used
for transplantation (N = 1). In the case of tumors, normal
renal tissue remote from the tumor was chosen for analy-
sis. Basic clinical data of these normal individuals is given
in Table 1. All individuals were Caucasian, except for
three children. Two were Native Canadians and one was
of Asian descent. None of the patients had diabetes mel-
litus or uncontrolled arterial hypertension. Table 2 shows
the histologic grading of these normal kidney specimens.
Based on the Banff classification for chronic allograft
nephropathy [32], a blinded renal pathologist (D.C.R.)
scored changes based on the percentage of parenchymal
involvement: interstitial fibrosis: 0, no interstitial fibro-
sis; 1, representing interstitial fibrosis in up to 25%; 2,
Table 1. Demographic data and histologic grading on the 42
individuals from whom normal kidneys were derived
Young Adult Old
N = 7 N = 11 N = 24
Mean age ± SD years 5.4 ± 7.4 39.5 ± 4.8 66.7 ± 11.0
Age range 8 weeks–21 years 31–47 years 50–88 years
Gender F/M 1/6 6/5 12/12
Creatinine lmol/L 45.8 ± 29.9 90.8 ± 19.8a 92.8 ± 16.9b
Ethnicity Caucasian/ 4/2/1 11/0/0 24/0/0
Native Canadian/
Asian
Systolic blood 86.3 ± 17.2 123.3 ± 18.4a 135.8 ± 18.9b
pressure mm Hg
Diastolic blood 44.3 ± 11.5 75.5 ± 9.5a 76.7 ± 11.9b
pressure mm Hg
Proteinuria None None None
History of hypertension 1 (14%) 1 (9%) 11 (46%)
History of diabetes None None None
mellitus
Histologic findings%
Glomerulosclerosis 0.43 ± 0.54 2.36 ± 1.91 8.54 ± 6.57c
Interstitial fibrosis 0.06 ± 0.18 0.18 ± 0.40 0.88 ± 0.54c
Tubular atrophy 0.06 ± 0.18 0.18 ± 0.41 1.10 ± 0.36c
Fibrous intimal 0 0.32 ± 0.46 1.24 ± 0.80c
thickening
Arteriolar hyalinosis 0.13 ± 0.35 0.27 ± 0.47 1.00 ± 0.80c
aP < 0.05 for adult vs. young; bP < 0.05 for old vs. young; cP < 0.05 for old vs. adult
and old vs. young
representing interstitial fibrosis in 26% to 50%; and 3,
representing interstitial fibrosis in more than 50% of the
cross section; tubular atrophy: 0, representing no tubular
atrophy; 1, representing tubular atrophy in up to 25%; 2,
representing tubular atrophy in 26% to 50%; and 3, rep-
resenting tubular atrophy in more than 50% of tubules;
arteriolar hyaline thickening: 0, no periodic acid-Schiff
(PAS)-positive hyaline thickening; 1, mild-to-moderate
PAS-positive hyaline thickening in at least one arteriole;
2, moderate-to-severe PAS-positive hyaline thickening in
more than one arteriole; 3, severe PAS-positive hyaline
thickening in many arterioles. Glomerulosclerosis was ex-
pressed as percentage of globally sclerosed glomeruli.
All tissue samples were snap-frozen in liquid nitrogen
and stored at−70◦C. In addition, tissue was embedded for
paraffin sections. The study was approved by the Health
Research Ethics Board of the University of Alberta,
Edmonton.
Real-time reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was extracted from tissue samples ac-
cording to a modification of the method described by
Chirgwin et al [33]. Tissues were homogenized with a
polytron in 4 mol/L guanidinium isothiocyanate, and
the RNA was pelleted through a 5.7 mol/L CsCl2 cush-
ion. RNA was isolated by phenol/chloroform extraction.
Concentrations were determined by absorbance at 260
nm. Transcription into cDNA was done using Moloney
murine leukemia virus (MMLV) reverse transcriptase
and random primers (Life Technologies, Burlington, On-
tario). The principle of real-time quantitative PCR has
been described by Heid et al [34]. cDNA was amplified
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Table 2. Sequences for primers and probes used in real-time polymerase chain reaction (PCR) studies
Name Accession # Forward primer Reverse primer Probe
p16INK4a L27211 GTAACCATGCCCGCATAGATG CTAAGTTTCCCGAGGAAA TCCCTCAGACATCCCCGATTG
TTTCTCAGA GAAC
p14ARF U40343 CTGATCTCCATCGCAGGGAC ATGTCCACGAGGTCCTGAGC CACCCTTGGAGCTGGCACT
GCAGA
LON U02389 AGAAGACCATTGCGGCCAA GAAGGCTGCCAGGTCGT CATCGTCCTGCCAGCCGAG
AGAA AACAA
PAI-1 M16006 CAGCTCATCAGCCACTGGAAA TCGGTCATTCCCAGGTTCTCT CGCCTCCTGGTTCTCTGCCC
AAGTTCT
COX-1 M59979 CTTCAATGAGTACCGCAAGA GTAGAACTCCAACGCATCAA CCATCTCCTTCTCTCCTACGA
GGTT TGTCT GCTCCTGGA
MMP-1 D31815 TTCAAGACAGAAAGAGACA GGTGACACCAGTGACTGCA TTGCCGGAGGAAAAGCAGCT
GGAGACA CAT CAAGAAC
HPRT NM 000194 GACTTTGCTTTCCTTGGTCAGG AGTCTGGCTTATATCCAA TTTCACCAGCAAGCTTGCGAC
CACTTCG CTTGA
Abbreviations are: PAI-1, plasminogen activator inhibitor-1; COX-1, cyclooxygenase-1; MMP-1, matrix metalloproteinase-1 HPRT, hypoxanthine guanine
phosphoribosyl transferase.
in an ABI PRISM 7700 Sequence Detector (Applied
Biosystems, Foster City, CA, USA). All samples were
done in duplicates and run in two separate experi-
ments. Sequence-specific primers and probe (Table 2)
for p16INK4a, p14ARF, LON protease, PAI-1, COX-1,
COX-2, MMP-1, and hypoxanthine guanine phosphori-
bosyl transferase (HPRT) were designed using Primer
Express Software (Applied Biosystems). Predeveloped
assay reagents (PDARs) for p53, p21CIP1/WAF1, HDM2,
CDK4, PCNA, GADD45, GADD153, RAD23, TGF-b1,
and HSPA5 (aka GRP78) were purchased (Applied
Biosystems). Quantification of gene expression was per-
formed using the standard curve method as described
in User Bulletin #2 (Applied Biosystems). Briefly, the
number of PCR cycles that are needed to reach the flu-
orescence threshold is called threshold cycle (Ct). The
Ct value for each sample is proportional to the log of
the initial amount of input cDNA. The Ct values for all
samples were normalized based on two standard curves
(gene of interest and HPRT). The amount for the gene
of interest is divided by the HPRT amount (normaliza-
tion to HPRT). Then the mean value for the duplicates
is calculated. The standard curve consisted of RNA from
Jurkat cells and two different human kidney samples.
Immunoperoxidase staining for p16INK4a, COX-1,
and COX-2
Immunoperoxidase staining for p16INK4a was per-
formed using 2 lm sections of paraffin embedded tis-
sue. Briefly, sections were deparaffinized and hydrated.
The sections were immersed in 3% H2O2 in methanol to
inactivate endogenous peroxidase. Slides were blocked
with 20% normal goat serum. Tissue sections were then
incubated for 1 hour at room temperature with the
primary antibody (mouse monoclonal antibody, Clone
F-12) (Santa Cruz Biotechnologies, Santa Cruz, CA,
USA), as described by others [35] and rinsed with
phosphate-buffered saline (PBS). Following 30 min-
utes of incubation with the Envision Monoclonal Sys-
tem (Dako, Mississauga, Ontario), sections were washed
again in PBS. Visualization was performed using the DAB
substrate kit (Dako). The slides were counterstained with
hematoxylin and mounted. Analysis was done by count-
ing 10 high power fields (HPF) by a blinded observer.
Percentage of positive nuclei was assessed for tubules,
glomeruli and interstitium. Each vessel was graded on a
scale from 0 to 3, with 0 being no staining, 1 up to 30%
stained nuclei, 2 between 30% and 60% stained nuclei
and 3 more than 60% stained nuclei. The mean score
was then calculated for each section. Tonsil was used as
a positive control.
For slides stained for COX-1, COX-2, or Ki-67, antigen
retrieval was performed by microwave cooking in citrate
buffer. The sections then were immersed in 3% H2O2
in methanol, blocked with 20% normal goat serum and
then incubated for 2 hours at room temperature with the
primary antibodies COX-1 (rabbit polyclonal antibody,
#160108) (Cayman Chemicals, Ann Arbor, MI, USA) and
COX-2 (rabbit polyclonal antibody, #160107) (Cayman
Chemicals), as described by others [36]; Ki-67 antigen
was detected with clone MIB-1 (Dako) and rinsed with
PBS. Following 30 minutes of incubation with the Envi-
sion Monoclonal System (Dako), sections were washed
again in PBS. Visualization was performed using the DAB
substrate kit (Dako). The slides were counterstained with
hematoxylin and mounted.
Statistics
Data analyses were performed using SPSS. Linear re-
gression was used to analyze the correlation between
expression of candidate genes and age. For calculating
the correlation between histologic scores and candidate
genes independent from age partial correlation analysis
was used. Age groups were defined as “young” for speci-
mens derived from individuals between 0 and 29 years of
age, “adult” for 30 to 49 year old individuals, and “old”
for individuals 50 years and older. These categories were
arbitrarily chosen to get approximately equal numbers in
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Fig. 1. P16INK4a mRNA expression in re-
nal cortex and medulla. (A) Regression for
p16INK4a mRNA expression in cortex (•)
(R2 = 0.47, P < 0.001) and medulla () (R2 =
0.03; P = 0.42) with age. (B) Mean (± SD)
of p16INK4a mRNA expression in three age
groups (young, adult, and old) in cortex
and medulla. ∗P < 0.001 for the comparison
with young and adult kidneys. RNA was iso-
lated and quantitative reverse transcription-
polymerase chain reaction (RT-PCR) was per-
formed using sequence-specific primer and
probe for p16INK4a on an ABI 7700 Se-
quence Detection System. Values are given as
p16INK4a/HPRT ratio (see Methods section).
each tertile. Means among age groups were compared
using analysis of variance (ANOVA), and t tests with
Bonferroni correction were used for multiple pair-wise
comparisons. All values are given as mean ± standard
deviation (SD).
RESULTS
p16INK4a mRNA expression in normal human
kidney samples
P16INK4a expression for kidney cortex specimens in-
creased with age as shown by linear regression analysis
(Fig. 1A) (R2 = 0.47; P < 0.001). This result was corrob-
orated by the comparison of cortical p16INK4a expression
for different age groups. Comparison of the three age
groups revealed highly significant differences in cortex
(P < 0.001) when “old” individuals where compared to
either “adult” or “young” (Fig. 1B).
The correlation with age in cortex was still significant
when we studied only patients older than 30 years (R2 =
0.36, P < 0.001) and when we studied only normotensive
patients (R2 = 0.64, P < 0.001). In the 13 individuals who
were hypertensive, the same trend was seen (R2 = 0.16,
P = 0.18), but because of the small case number this did
not reach significance.
Mean p16INK4a expression was not significantly dif-
ferent between cortex and medulla. However, p16INK4a
expression in “young” was higher in medulla when com-
pared to cortex, and p16INK4a expression in medulla did
not increase significantly with age (R2 = 0.03; P = 0.42)
(Fig. 1A). The expression of p16INK4a mRNA was not sig-
nificantly different among the three age groups in medulla
(Fig. 1B).
All analyses were done for both female and male indi-
viduals separately and revealed no significant differences
in gender.
p16INK4a protein expression in normal human
kidney sections
p16INK4a protein expression was observed as nuclear
and cytoplasmic staining. We evaluated the extent of nu-
clear p16INK4a staining in the renal cortex in tubules,
glomeruli, in interstitial cells, and in arteries (Fig. 2).
Tubular staining occurred in all parts of the nephron, but
was pronounced in distal tubules and collecting ducts. Nu-
clear staining was rare in proximal tubular epithelium. In
glomeruli, parietal epithelium and podocytes stained. The
p16INK4a-positive cells in arteries were mostly vascular
smooth muscle cells and rarely endothelial cells. Nuclear
p16INK4a expression increased with age in all cell types
examined. The increase was more pronounced in tubu-
lar cells (P < 0.001) (Fig. 3A) but was also statistically
significant in glomerular and interstitial cells (P < 0.05)
(Fig. 3B and C). Young kidneys showed staining of 7.8%
(±10.2%) of tubular nuclei, 11% (±15.9%) of glomerular
nuclei, and 2% (±3.2%) of interstitial cell nuclei. Adult
kidneys showed similar staining: 7.8% (±8.1%) of tubu-
lar, 7.9% (±14.3%) of glomerular, and 2.2% (±3.8%) of
interstitial cell nuclei showed nuclear p16INK4a staining. In
contrast, in “old” kidneys p16INK4a staining was observed
in 30.8% (±18.4%) of tubular nuclei, 20.8% (±15.6%) of
glomerular nuclei, and 11.4% (±13%) of interstitial cell
nuclei. We also found a significant increase with age in
arteries (P < 0.05) (Fig. 3D).
In addition to the nuclear staining, we observed in some
cases a fine granular cytoplasmic staining for p16INK4a.
This staining was seen in 54% (13 of 24) of the “old”
kidneys, 18% (2 of 11) of the “adult” kidneys but in none
of the “young” kidneys (P < 0.005, v 2 test). Cytoplasmic
staining was mainly localized to distal tubules, including
the macula densa, and occasionally to the collecting duct
(Fig. 2H and I).
Expression of proliferation marker Ki-67 in relation
to p16INK4a protein expression
As p16INK4a is a cell cycle regulator that should lead
to a decrease in proliferation, we sought to assess the
amount of proliferation by determining the proliferation
marker Ki-67 in tubular epithelium. We correlated the
amount of Ki-67 with p16INK4a as assessed by immuno-
histochemistry. As expected, Ki-67 expression showed an
inverse correlation (R2 = 0.184, P < 0.01) with p16INK4a
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Fig. 2. Representative pictures of p16INK4a staining in kidney. P16INK4a
staining was either nuclear or cytoplasmic and increased with age.
Nuclear p16INK4a staining was detected in most renal cell types. It
occurred along the whole nephron, but was pronounced in distal
tubules (A) and collecting ducts (B). In glomeruli (C), podocytes
(arrowhead) and parietal epithelium (arrow) stained. The juxta-
glomerular apparatus showed either nuclear (D) or cytoplasmic
staining (E) [macula densa (MD) cells, extraglomerular mesangium
(EM), and glomerulus (GM)]. The p16INK4a-positive cells in arteries
were mostly vascular smooth muscle cells (F, arrowheads) and rarely
endothelial cells (not shown). In the medulla (G), collecting ducts, en-
dothelial cells of peritubular capillaries (arrowhead), medullary stro-
mal cells (arrows), and epithelial cells of thin limbs (star) showed nu-
clear p16INK4a staining. We also observed in some cases a fine gran-
ular cytoplasmic staining for p16INK4a. This staining was mainly seen
in distal tubules (H), including the area of the macula densa (E), and
occasionally in collecting ducts (I). Of note, within one tubule, some
cells could show nuclear and cytoplasmic staining (H and I, arrows),
whereas others only showed cytoplasmic staining but no nuclear stain-
ing (H and I, arrowheads). p16INK4a staining was patchy. Adjacent
tubules could be completely free of staining. p16INK4a staining was also
found in atrophic tubules as shown by sequential sectioning: Atrophic
tubules (1 to 3) were identified in periodic acid-Schiff (PAS)-stained
sections (J) and the corresponding tubules in the immunoperoxidase
stain (K) were identified (original magnification 400×).
expression compatible with the view that the tubular
p16INK4a expression leads to cell cycle arrest.
Expression of candidate senescence genes
in human kidney cortex
In addition to p16INK4a, we examined renal expres-
sion of a number of genes that had been associated with
cellular senescence in vitro. Table 3 shows the gene to
HPRT ratios in the three age groups and Table 4 the re-
gression analysis for the sixteen additional genes studied.
Comparison of the three age groups showed significant
increases with age for COX-1, COX-2, and CDK4. Re-
gression analysis revealed significant changes for COX-1,
COX-2, CDK4, MMP-1, and HSPA5. However, only
COX-1 and COX-2 showed a significant increase in ex-
pression with age in renal cortex (regression coefficient
R2 > 0.16, equivalent to r > 0.4). These results were ro-
bust in that they remained essentially the same when nor-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 5. Representative pictures of cyclooxygenase-1 (COX-1) and
cyclooxygenase-2 (COX-2) staining in kidney. COX-1 expression was
higher in the medulla, where the collecting ducts (A), thin limbs of
Henle, and the urothelium (B) stained. Cortical staining occurred in
parietal epithelium of Bowman’s capsule (C, arrowheads) and in dis-
tal convoluted tubules (D). COX-2 staining was more abundant in the
renal cortex than COX-1 staining. It was present in distal convoluted
tubules, predominately in the area of the macula densa (E). In glomeruli
(F), the epithelium of Bowman’s capsule (arrowheads) and occasional
podocytes (arrow) in the glomerular tuft stained. Furthermore, vascular
smooth muscle cells in arteries (G, arrowheads) and glomerular arteri-
oles showed COX-2 staining. In the medulla, COX-2 was expressed in
the collecting duct epithelium (H) and the urothelium (not shown), but
this was at lower levels than for COX-1 (original magnification 400×).
motensives and hypertensives were analyzed separately.
No differences in gender were found.
COX-1 and COX-2 mRNA expression in normal
human kidney
We further compared COX-1 and COX-2 expression
in cortex versus medulla (Fig. 4). The mean values for
COX-1 were significantly higher in medulla compared
to cortex (P < 0.001). In cortex, COX-1 mRNA expres-
sion increased significantly with age (Fig. 4A) (R2 = 0.18,
P = 0.005). This increase remained significant, when only
patients older than 30 years (R2 = 0.13, P < 0.05) or
only normotensive patients were analyzed (R2 = 0.25,
P < 0.01). The increase in COX-1 mRNA expression
in medulla with age was not significant (Fig. 4A) (R2 =
0.06, P = 0.25). When we compared the mean values for
COX-1 mRNA expression in the three age groups, we
confirmed that cortex of “old” kidneys showed higher
COX-1 mRNA expression than cortex of “young” or
“adult” kidney (P < 0.05) (Fig. 4B).
Unlike COX-1, COX-2 mRNA expression was similar
in cortex versus medulla. However, like COX-1, COX-2
mRNA increased significantly with age in cortex (R2 =
0.19, P < 0.005) (Fig. 4C), whereas the increase in medulla
was not significant (R2 = 0.09, P = 0.16). Analysis of re-
gression in cortex, including only normotensive patients,
was also significant (R2 = 0.39, P < 0.001). When only
samples from patients older than 30 years were analyzed,
the correlation with age in cortex was borderline (R2 =
0.10, P = 0.06). Comparison of mean values for COX-2
mRNA expression in cortex in the three age groups re-
vealed significant differences only between “old” versus
“young” (P < 0.05) (Fig. 4D).
COX-1 and COX-2 protein expression in normal
human kidney sections
COX-1 and COX-2 protein expression was increased
in “old” kidney as documented by immunohistochemistry
(Fig. 5). COX-1 staining mainly localized to the medulla,
in keeping with the higher mRNA expression in medulla.
In “young” kidneys, COX-1 staining was minimal, local-
izing to the collecting duct and the urothelium. In “old”
kidneys, COX-1 staining was increased, and localized to
the collecting duct, the thin limb of Henle, and the urothe-
lium. In addition, “old” kidneys showed cortical staining
for COX-1 in distal convoluted tubules and in parietal
epithelium of Bowman’s capsule. We did not observe vas-
cular COX-1 staining, unlike some previous reports [36].
COX-2 staining was found in cortex and medulla. In
“old” kidneys there was much more staining than in
“young” kidneys, but the staining pattern was similar.
COX-2 staining in cortex was present in the distal con-
voluted tubules, predominantly in the macula densa, in
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Fig. 3. P16INK4a protein expression in renal cortex. (A) Tubules. (B) Glomeruli. (C) Interstitium. (D) Arteries. The increase with age was significant
for all cell types investigated (slope, R2, and P values are shown), but most pronounced for tubular cells. Immunoperoxidase staining for p16INK4a
was assessed as percentage of positive nuclei for tubular, glomerular and interstitial cells in 10 high power fields. Arteries were graded on a scale
from 0 to 3 (0 = no staining of smooth muscle cells, 1 = up to 30% stained nuclei, 2 = 30% to 60% stained nuclei, 3 = >60% stained nuclei), the
whole section was scored and a mean score was calculated.
Table 3. Expression of candidate senescence genes (mean ±
standard deviation) for kidney cortex in three different age groups
(numbers are gene/HPRT ratio)
Gene Young Adult Old
p16INK4a 0.16 ± 0.21 0.41 ± 0.23 1.05 ± 0.56a
CDK4 0.98 ± 0.36 1.08 ± 0.26 1.24 ± 0.19b
p53 0.46 ± 0.23 0.36 ± 0.09 0.46 ± 0.21
p21CIP1/WAF1 1.06 ± 0.83 1.14 ± 0.87 1.24 ± 1.01
GADD45 2.47 ± 1.70 3.71 ± 1.59 3.03 ± 1.15
p14ARF 0.63 ± 0.29 0.46 ± 0.09 0.55 ± 0.17
HDM2 0.88 ± 0.35 0.77 ± 0.18 0.96 ± 0.34
PCNA 0.57 ± 0.18 0.56 ± 0.11 0.55 ± 0.07
RAD23 1.24 ± 0.42 1.22 ± 0.39 1.41 ± 0.53
PAI-1 1.88 ± 1.91 4.50 ± 5.08 3.05 ± 3.86
COX-1 0.14 ± 0.10 0.17 ± 0.08 0.31 ± 0.19a
COX-2 0.82 ± 0.35 1.18 ± 0.38 1.94 ± 1.27b
MMP-1 1.51 ± 2.19 0.76 ± 0.40 0.60 ± 0.27
TGF-b1 0.62 ± 0.24 0.51 ± 0.20 0.73 ± 0.35
LON protease 1.91 ± 0.93 1.69 ± 0.43 2.00 ± 0.75
HSPA5 2.47 ± 2.96 1.21 ± 0.42 1.29 ± 0.44
GADD153 5.93 ± 3.73 6.62 ± 7.26 4.40 ± 3.46
Abbreviations are: CDK4, cyclin dependent kinase 4; GADD45, growth arrest
and DNA-damage inducible protein 45; HDM2, human double minute 2; PCNA,
proliferating cell nuclear antigen; PAI-1, plasminogen activator inhibitor-1, COX-
1 and COX-2, cyclooxygenase 1 and 2; MMP-1, matrix metalloproteinase-1; TGF-
b1, transforming growth factor-b1; HSPA5, heat shock protein A5; GADD153,
growth arrest and DNA-damage inducible protein 153.
aAt least P < 0.05 for old vs. adult and old vs. young.
bAt least P < 0.05 for old vs. young.
glomerular epithelium of Bowman’s capsule, and in some
podocytes in the glomerular tuft. In the medulla, COX-2
staining was seen in stromal cells, the collecting duct, and
the urothelium. Furthermore, vascular smooth muscle
Table 4. Linear regression analysis for gene expression in kidney
cortex with age
Gene Slope R2 P value
p16INK4a +0.0160 0.465 <0.001
CDK4 +0.0038 0.131 0.02
p53 +0.0003 0.001 0.84
p21CIP1/WAF1 +0.0028 0.006 0.64
GADD45 +0.0016 0.001 0.86
p14ARF −0.0012 0.026 0.31
HDM2 +0.0022 0.030 0.28
PCNA −0.0005 0.012 0.50
RAD23 +0.0024 0.015 0.44
PAI-1 +0.0065 0.002 0.80
COX-1 +0.0030 0.182 0.005
COX-2 +0.0188 0.186 0.004
MMP-1 −0.0128 0.113 0.03
TGF-b1 +0.0019 0.023 0.34
LON protease +0.0029 0.010 0.52
HSPA5 −0.0175 0.111 0.03
GADD153 −0.0312 0.026 0.31
Abbreviations are: CDK4, cyclin dependent kinase 4; GADD45, growth arrest
and DNA-damage inducible protein 45; HDM2, human double minute 2; PCNA,
proliferating cell nuclear antigen; PAI-1, plasminogen activator inhibitor-1, COX-
1 and COX-2, cyclooxygenase 1 and 2; MMP-1, matrix metalloproteinase-1; TGF-
b1, transforming growth factor-b1; HSPA5, heat shock protein A5; GADD153,
growth arrest and DNA-damage inducible protein 153.
cells in arcuate and interlobular arteries and in glomeru-
lar arterioles showed COX-2 staining.
Lipofuscin in human kidney samples
Lipofuscin was found in none of the “young” kidneys,
in a third of the “adult” kidneys and in all “old” kidneys.
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Fig. 4. Cyclooxygenase-1 and –2 (COX-1 and
COX-2) mRNA expression in renal cortex
and medulla. (A) Regression for COX-1
mRNA expression in cortex (R2 = 0.18, P
= 0.005) and medulla (R2 = 0.06, P = 0.25)
with age. (B) Mean (± SD) of COX-1 mRNA
expression in three age groups (young, adult,
and old) in cortex and medulla. ∗P < 0.05 for
the comparison with young and with adult kid-
neys. (C) Regression for COX-2 mRNA ex-
pression in cortex (R2 = 0.19, P = 0.004) and
medulla (R2 = 0.09, P = 0.16) with age. (D)
Mean (± SD) of COX-2 mRNA expression
in three age groups (young, adult, and old) in
cortex and medulla. #P < 0.05 for the compar-
ison with young kidneys. Values are given as
either COX-1/HPRT or COX-2/HPRT ratio
(see Methods section).
Lipofuscin was found in tubular cells but not in glomeruli.
It was mainly localized in the medulla in “adult” kidneys,
but “old” kidneys developed lipofuscin in a small number
of cortical tubules. Thus as expected lipofuscin increased
with age. The distribution of lipofuscin and the increase
in cortex in “old” kidneys were similar to what we had
observed in rat kidneys with age [10].
Gene expression in correlation with histologic changes
In addition to age related changes we examined the cor-
relation between expression of the candidate genes and
the main histologic features of age: glomerulosclerosis, in-
terstitial fibrosis, and tubular atrophy (Table 5). The num-
ber of sclerotic glomeruli correlated significantly with
p16INK4a and p53 expression; the correlation with COX-1
was borderline significant. Interstitial fibrosis and tubu-
lar atrophy each correlated with p16INK4a, p53, COX-1,
TGF-b , and HSPA5 expression. The expression of
p14ARF only correlated with tubular atrophy.
DISCUSSION
We studied whether cells in old human kidneys show
features of cellular senescence as observed in cultured
somatic cells. The striking finding was that, in renal cor-
tex, age increased the expression of the cyclin-dependent
kinase inhibitor p16INK4a, a marker and possible medi-
ator of aspects of the senescence phenotype in mouse
and human cultured cells [37–39]. The steady state
mRNA levels were increased about 10-fold in cortex,
associated with nuclear and cytoplasmic staining by
immunohistochemistry. COX-1 and COX-2 increased
with age in cortex, but other candidate senescence or ag-
Table 5. Age-corrected partial correlation for gene expression in
kidney cortex with glomerulosclerosis, interstitial fibrosis, and tubular
atrophy
Interstitial Tubular
Glomerulosclerosis fibrosis atrophy
Gene R P value R P value R P value
p16INK4a 0.553 <0.001 0.477 <0.01 0.406 <0.01
CDK4 0.092 0.58 0.003 0.99 0.183 0.27
p53 0.377 0.02 0.366 0.02 0.580 <0.001
p21CIP1/WAF1 0.155 0.35 0.212 0.19 0.185 0.26
GADD45 −0.137 0.41 −0.007 0.97 −0.021 0.90
p14ARF 0.003 0.99 0.185 0.25 0.427 <0.01
HDM2 0.011 0.95 0.024 0.88 0.177 0.28
PCNA 0.104 0.54 0.142 0.39 0.265 0.10
RAD23 −0.088 0.60 0.026 0.88 0.210 0.20
PAI-1 −0.060 0.72 0.058 0.72 −0.007 0.97
COX-1 0.315 0.05 0.446 <0.01 0.473 <0.01
COX-2 0.085 0.61 0.229 0.16 0.166 0.31
MMP-1 −0.041 0.80 0.122 0.46 0.104 0.52
TGF-b1 0.258 0.12 0.398 0.01 0.627 <0.001
LON protease −0.246 0.13 0.045 0.79 0.155 0.34
HSPA5 0.165 0.32 0.544 <0.001 0.656 <0.001
GADD153 0.061 0.72 −0.199 0.22 −0.188 0.25
Abbreviations are: CDK4, cyclin dependent kinase 4; GADD45, growth arrest and
DNA-damage inducible protein 45; HDM2, human double minute 2; PCNA, proliferat-
ing cell nuclear antigen; PAI-1, plasminogen activator inhibitor-1, COX-1 and COX-2,
cyclooxygenase 1 and 2; MMP-1, matrix metalloproteinase-1; TGF-b1, transforming
growth factor-b1; HSPA5, heat shock protein A5; GADD153, growth arrest and DNA-
damage inducible protein 153.
ing genes did not. As expected, lipofuscin increased in
renal cells. In an age-corrected comparison between gene
expression and histologic features, p16INK4a and p53 cor-
related with glomerulosclerosis, interstitial fibrosis, and
tubular atrophy. COX-1, TGF-b , and HSPA5 correlated
with interstitial fibrosis and tubular atrophy; p14ARF only
correlated with tubular atrophy. This data, taken together
with our previous finding that telomere shortening occurs
in renal cortex with age [9], suggest that some changes
typical of cellular senescence in vitro occur in human
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kidney cortex with age and could contribute to the phe-
notype of renal aging, but others do not. Thus, the only
gene that independently correlated with aging and with
histologic changes (glomerulosclerosis, tubular atrophy,
and interstitial fibrosis) was p16INK4a. This raises the pos-
sibility that p16INK4a induction is a primary event in aging,
whereas others such as TGF-b could be secondary as part
of the atrophy and fibrosis process.
The increase in p16INK4a expression in kidney with age
suggests that many cells in human kidney eventually un-
dergo cell cycle regulatory events during development
and aging similar to those in senescent fibroblasts in cul-
ture. p16INK4a was found in almost all cell types in kidney,
but mainly in tubular cells. In “young” kidneys p16INK4a
expression was higher in medulla than in cortex, recall-
ing our earlier observation that telomeres are shorter in
medulla than in cortex in “young” kidneys, and suggest-
ing that the replicative history of medullary cells in de-
velopment is different from that of cortical cells. These
differences reflect differences in development, such as the
greater net contribution of ureteric bud to the medulla.
The strong p16INK4a expression in the collecting duct,
which is derived from the ureteric bud, is compatible with
this possibility. Nevertheless, during adult life p16INK4a
expression, like telomere shortening, increases mainly in
cortex, which is where the loss of renal mass is greater in
aging. The age-related induction of p16INK4a and telom-
ere shortening in cortex supports the concept that cellular
senescence mechanisms contribute to renal aging.
Based on studies of fibroblasts in culture, the increase
in p16INK4a can be triggered either by injury from envi-
ronmental stress or by replication in aged human kidney.
Increases in p16INK4a expression through replication are
at least partially independent of telomere shortening [38,
40], since p16INK4a expression occurs in mouse fibrob-
lasts, which do not show telomere shortening. Similarly,
we have shown striking induction of p16INK4a in rat [10]
and mouse (Melk et al, unpublished data) kidneys with
age, in the absence of telomere shortening. Our working
hypothesis is that telomere shortening reflects replicative
stress, and that p16INK4a reflects primarily environmental
stress, but neither of these interpretations is proven.
Widespread p16INK4a expression in “old” kidneys could
be both beneficial and detrimental. P16INK4a induction,
by inducing irreversible cell cycle arrest, could operate as
a defense against cancer but also limit renal repair and
long-term preservation of renal mass, especially during
abnormal stresses. This in turn could be relevant to the
high incidence of end-stage renal disease in the elderly.
Such a role for p16INK4a is supported by in vitro data
on p16INK4a in other cell types in vitro, but also by the
inverse correlation between p16INK4a protein expression
and replication of tubular cells, as shown by Ki-67 staining
in the present studies. In addition, p16INK4a can affect in-
tegrin expression. In some cell lines, it increases the a5 in-
tegrin chain of the a5b1 fibronectin receptor [41], leading
to apoptosis upon loss of anchorage. It also inhibits avb3
integrin receptor mediated cell spreading [42]. The inter-
actions between p16INK4a and integrins could be relevant
to tubular atrophy. The fact that some cells show cyto-
plasmic p16INK4a staining would be compatible with roles
for p16INK4a beyond CDK regulation. Overall, the sig-
nificance of cytoplasmic p16INK4a staining has been con-
troversially discussed. In some publications cytoplasmic
p16INK4a staining has been shown to be associated with
more aggressive tumors [43, 44]; others suggest that it
has no specific significance [45]. In our own studies, cyto-
plasmic p16INK4a staining was only found in older human
kidneys, but could not be detected in any of the rodent
kidneys [10] (Melk et al, unpublished data).
The increases in COX-1 and COX-2 could be either a
primary manifestation of aging or a secondary compen-
sation. In microarray studies of aged fibroblasts, COX-1
is increased, but COX-2 is decreased [24]. Thus we have
to consider that at least COX-1 could be increased as a di-
rect consequence of age. However, it is also possible that
COX-1 and COX-2 are increased to compensate for the
rise in renal vascular resistance, which is a striking feature
of renal aging. Both COX-1 and COX-2 maintain renal
perfusion by increasing renal blood flow and glomerular
filtration rate through their metabolites prostaglandin E2
(PGE2) and prostaglandin I2 (PGI2) [46]. Renal perfu-
sion in old kidneys may be more dependent on vasodila-
tor prostaglandins. The clinical observation that acute
renal failure due to COX inhibition is more frequent in
the elderly is compatible with this belief [47]. COX-2 from
the macula densa also regulates renin release from the
juxtaglomerular apparatus [48, 49]. This highlights the
general problem of distinguishing the events that cause
aging from the events that occur as consequences of or as
compensation for age-related changes.
The fact that some genes correlated with fibrosis and
atrophy but not with age indicates that such genes may
be induced by age-related renal deterioration rather than
by age per se. For example, TGF-b did not correlate with
age but did correlate with tubular atrophy and interstitial
fibrosis. This conclusion is in line with our finding that
TGF-b did not correlate significantly with age in rat kid-
neys [10], and with the strong association of TGF-b with
fibrosis and atrophy in many other types of renal injury
and disease. Thus we may eventually be able to distin-
guish those primary events caused by aging from those
secondary to age-related deterioration.
The studies of the molecular events in aging in hu-
man kidney versus rodent kidneys converge to suggest
both similarities (e.g., p16INK4a) and differences (e.g.,
telomere shortening) in the aging phenotype. Of inter-
est, the kidney in each species showed features observed
in senescent fibroblasts of that species. Thus human kid-
neys and fibroblasts show increased p16INK4a expression,
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without change in p14ARF, but with telomere shorten-
ing [9], whereas mouse kidneys and fibroblasts show
increased p16INK4a and to a lesser extent in p19ARF ex-
pression without telomere shortening [abstract; Melk
et al, Am J Transplant 2:221, 2002] (Melk et al, unpub-
lished data). Our preliminary results with human and
mouse cDNA microarrays also indicate that relatively
few genes manifest significant changes in expression in
human renal aging [abstract; Melk et al, Am J Transplant
2:383, 2002] (Melk et al, unpublished data). Species differ-
ences in aging mechanisms are not surprising. Long-lived
mammals require different regulatory strategies than
those in short-lived mammals (e.g., superior resistance
to cancer through the telomere shortening mechanism)
[50], and increased resistance to environmental stress to
permit long survival of postmitotic cells. Parallel in vitro
and in vivo studies in a number of species will be helpful in
defining the significance of each component of the aging
phenotype.
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